XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
FI Fiserv
- 230.600
- +0.730+0.32%
Close Feb 14 16:00 ET
- 230.600
- 0.0000.00%
Post 20:01 ET
131.19BMarket Cap42.86P/E (TTM)
232.650High230.000Low2.11MVolume230.950Open229.870Pre Close488.10MTurnover0.37%Turnover Ratio42.86P/E (Static)568.92MShares233.26052wk High4.85P/B130.23BFloat Cap145.98052wk Low--Dividend TTM564.73MShs Float233.260Historical High--Div YieldTTM1.15%Amplitude2.407Historical Low231.211Avg Price1Lot Size
Fiserv Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 28.46%6.63B | 39.25%2.22B | 43.55%2.24B | 52.73%1.34B | -26.46%831M | 11.78%5.16B | -2.33%1.6B | 32.12%1.56B | -11.31%878M | 38.65%1.13B |
| Net income from continuing operations | 1.63%3.18B | 6.64%948M | -41.07%571M | 30.79%909M | 30.56%752M | 21.19%3.13B | 11.40%889M | 96.55%969M | 14.12%695M | -15.54%576M |
| Operating gains losses | 707.89%924M | 3,033.33%282M | 459.77%626M | 366.67%8M | -50.00%8M | 44.53%-152M | 136.00%9M | -231.82%-174M | 97.66%-3M | 106.32%16M |
| Depreciation and amortization | -0.83%3.1B | -1.17%758M | 1.17%778M | -1.88%785M | -1.40%774M | -1.51%3.12B | -0.52%767M | -2.66%769M | -1.11%800M | -1.75%785M |
| Deferred tax | -29.55%-662M | 26.35%-123M | -110.13%-332M | -84.85%-183M | 72.41%-24M | 8.42%-511M | -7.05%-167M | -85.88%-158M | 26.12%-99M | 52.46%-87M |
| Other non cash items | -71.11%26M | -238.71%-86M | 666.67%69M | 120.00%22M | 133.33%21M | 172.73%90M | 3,000.00%62M | 50.00%9M | -9.09%10M | -35.71%9M |
| Change In working capital | 62.94%-338M | 882.22%352M | 664.29%428M | 52.31%-310M | -195.97%-808M | -22.58%-912M | -133.33%-45M | 121.37%56M | -121.84%-650M | 15.74%-273M |
| -Change in receivables | -834.78%-169M | 65.63%-33M | 433.33%40M | -44.35%-179M | -98.82%3M | 102.99%23M | 61.45%-96M | 92.41%-12M | 59.08%-124M | 525.00%255M |
| -Change in prepaid assets | 49.62%-398M | 136.97%105M | -9.21%-83M | 49.03%-105M | -40.63%-315M | -212.25%-790M | -468.00%-284M | -461.90%-76M | -119.15%-206M | -72.31%-224M |
| -Change in payables and accrued expense | 888.89%426M | 17.27%292M | 115.56%582M | 103.80%9M | -36.01%-457M | -110.57%-54M | -38.67%249M | 4,600.00%270M | -225.40%-237M | -330.77%-336M |
| -Change in other working capital | -116.48%-197M | -113.95%-12M | 11.90%-111M | 57.83%-35M | -221.88%-39M | 60.78%-91M | 207.14%86M | -5.88%-126M | 2.35%-83M | 157.14%32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 28.46%6.63B | 39.25%2.22B | 43.55%2.24B | 52.73%1.34B | -26.46%831M | 11.78%5.16B | -2.33%1.6B | 32.12%1.56B | -11.31%878M | 38.65%1.13B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -125.09%-2.4B | -85.47%-664M | -449.48%-533M | -170.90%-810M | -26.43%-397M | 49.43%-1.07B | 38.06%-358M | 74.06%-97M | 71.79%-299M | -214.00%-314M |
| Capital expenditure reported | -13.04%-1.57B | -12.71%-399M | -13.24%-402M | -2.35%-348M | -23.89%-420M | 6.15%-1.39B | -6.95%-354M | 17.44%-355M | 12.14%-340M | -2.42%-339M |
| Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | 129.78%221M | 96.04%-11M | ---- | ---- | ---- |
| Net investment purchase and sale | -176.47%-94M | -478.95%-110M | 1,175.00%43M | -350.00%-27M | --0 | -17.24%-34M | -733.33%-19M | 20.00%-4M | 72.73%-6M | 0.00%-5M |
| Net other investing changes | -26,600.00%-801M | ---156M | -19,300.00%-194M | -22,700.00%-452M | 125.00%1M | ---3M | --0 | ---1M | --2M | ---4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -125.09%-2.4B | -85.47%-664M | -449.48%-533M | -170.90%-810M | -26.43%-397M | 49.43%-1.07B | 38.06%-358M | 74.06%-97M | 71.79%-299M | -214.00%-314M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4.38%-4.17B | -50.00%-1.98B | 16.72%-1.07B | -53.91%-925M | 83.55%-189M | -75.79%-4.36B | -3.04%-1.32B | -190.29%-1.29B | -286.07%-601M | -6.69%-1.15B |
| Net issuance payments of debt | 51.92%1.67B | 61.76%-156M | -597.75%-443M | 80.69%992M | 46.88%1.27B | 650.68%1.1B | -7.65%-408M | 18.67%89M | -10.44%549M | 631.29%866M |
| Net common stock issuance | -21.46%-5.74B | -32.27%-1.33B | -5.80%-1.24B | -46.52%-1.54B | -8.93%-1.64B | -86.95%-4.73B | -40.42%-1B | -45.23%-1.17B | -107.72%-1.05B | -199.60%-1.5B |
| Net other financing activities | 87.60%-90M | -639.13%-496M | 401.48%612M | -276.24%-380M | 133.85%174M | -656.25%-726M | 149.20%92M | -170.24%-203M | -146.98%-101M | -24.46%-514M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4.38%-4.17B | -50.00%-1.98B | 16.72%-1.07B | -53.91%-925M | 83.55%-189M | -75.79%-4.36B | -3.04%-1.32B | -190.29%-1.29B | -286.07%-601M | -6.69%-1.15B |
| Net cash flow | ||||||||||
| Beginning cash position | -7.17%2.96B | 15.57%3.47B | -1.89%2.8B | 10.95%3.19B | -7.17%2.96B | -0.41%3.19B | -10.96%3.01B | -6.76%2.86B | 1.52%2.88B | -0.41%3.19B |
| Current changes in cash | 123.66%62M | -409.64%-423M | 260.23%634M | -1,690.91%-394M | 173.57%245M | -1,035.71%-262M | 63.27%-83M | -51.52%176M | -108.70%-22M | 8.01%-333M |
| Effect of exchange rate changes | -196.97%-32M | -239.02%-57M | 237.04%37M | 150.00%5M | -200.00%-17M | 180.49%33M | -4.65%41M | 47.06%-27M | 108.70%2M | 270.00%17M |
| End cash Position | 1.01%2.99B | 1.01%2.99B | 15.57%3.47B | -1.89%2.8B | 10.95%3.19B | -7.17%2.96B | -7.17%2.96B | -10.96%3.01B | -6.76%2.86B | 1.52%2.88B |
| Free cash flow | 34.13%5.06B | 46.82%1.82B | 52.49%1.84B | 84.57%993M | -48.04%411M | 20.23%3.77B | -4.69%1.24B | 60.53%1.2B | -10.78%538M | 63.43%791M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?